In Other Journals

Ann Gregory
Med J Aust 2004; 180 (4): . || doi: 10.5694/j.1326-5377.2004.tb05851.x
Published online: 16 February 2004

The patient with the first probable case of variant Creutzfeldt-Jakob disease (vCJD) contracted after a blood transfusion has died. The death has prompted an editorialist to outline the expensive, intrusive but necessary steps in preventing further human-to-human transmission in the UK. Many people who were caught up in the surgical web spun out from recipients of "at vCJD risk" blood and blood products will need to be managed as if vCJD had been diagnosed. They may also need to accept restrictions on what they can do until we know more, so as not to expose others to potential risk.

  • Ann Gregory



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.